- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 30.87M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $339.31K |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $362.39K |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $237.3K |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $249.61K |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $0 |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $5.51K |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $73.32M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $77.84M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $31.01M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $29.11M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $55.91M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $54.61M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $62.94M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $65.92M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $129.34M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $132.57M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $12.55M |
| Cash And Equivalents restated | Q1 2025 · Mar 31, 2024 | $20.15M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 30.83M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $327.59K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$8.86M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.30 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $5.92M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $1.51M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$9.23M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$7.87M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $169.21K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $2.17M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $2.34M |